We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+15.73%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$11.4B
AUM Growth
+$1.02B
Cap. Flow
-$761M
Cap. Flow %
-6.65%
Top 10 Hldgs %
38.51%
Holding
1,217
New
80
Increased
450
Reduced
355
Closed
36

Sector Composition

Rank Sector Weight
1 Real Estate 74.34%
2 Technology 3.93%
3 Industrials 3.02%
4 Financials 2.65%
5 Healthcare 2.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RSX
951
DELISTED
VanEck Russia ETF
RSX
$33K ﹤0.01%
1,600
-500
-24% -$10.3K
PS
952
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
$33K ﹤0.01%
+1,030
New +$30.5K
CVSA
953
Covista Inc
CVSA
$4.09B
$32K ﹤0.01%
690
+190
+38% +$9.14K
GWPH
954
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$31K ﹤0.01%
184
-7
-4% -$1.04K
CPL
955
DELISTED
CPFL Energia S.A.
CPL
$31K ﹤0.01%
2,000
ASND icon
956
Ascendis Pharma A/S
ASND
$16.6B
$30K ﹤0.01%
256
-21
-8% -$1.84K
KYNB
957
Kyntra Bio
KYNB
$28.5M
$30K ﹤0.01%
22
-2
-8% -$2.71K
NVCR icon
958
NovoCure
NVCR
$1.97B
$29K ﹤0.01%
604
+110
+22% +$5.29K
HZNP
959
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$29K ﹤0.01%
+1,079
New +$25.6K
SAFE
960
DELISTED
Safehold Inc.
SAFE
$28K ﹤0.01%
1,300
ONCE
961
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$27K ﹤0.01%
241
+37
+18% +$2.72K
ACAD icon
962
Acadia Pharmaceuticals
ACAD
$4.35B
$25K ﹤0.01%
915
-37,773
-98% -$882K
AGIO icon
963
Agios Pharmaceuticals
AGIO
$2.2B
$25K ﹤0.01%
371
+57
+18% +$3.32K
RARE icon
964
Ultragenyx Pharmaceutical
RARE
$2.65B
$25K ﹤0.01%
358
+98
+38% +$5.6K
BEDU
965
DELISTED
Bright Scholar Education Holdings
BEDU
$23K ﹤0.01%
550
STG
966
Sunlands Technology
STG
$47.4M
$23K ﹤0.01%
+513
New +$28.7K
IMMU
967
DELISTED
Immunomedics Inc
IMMU
$23K ﹤0.01%
1,214
-126
-9% -$2.03K
CBPO
968
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$23K ﹤0.01%
250
-23
-8% -$1.88K
BPMC
969
DELISTED
Blueprint Medicines
BPMC
$22K ﹤0.01%
280
+40
+17% +$2.96K
EWW icon
970
iShares MSCI Mexico ETF
EWW
$1.91B
$22K ﹤0.01%
500
-400
-44% -$17.6K
INFN
971
PUT
DELISTED
Infinera Corporation Common Stock
INFN
$21K ﹤0.01%
7,000
ICPT
972
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$21K ﹤0.01%
189
-20
-10% -$2.19K
CLPR
973
Clipper Realty
CLPR
$46.4M
$20K ﹤0.01%
1,500
QQQ icon
974
PUT
Invesco QQQ Trust
QQQ
$449B
$20K ﹤0.01%
+500
New +$84.8K
FOLD
975
DELISTED
Amicus Therapeutics
FOLD
$19K ﹤0.01%
1,423
+504
+55% +$6.16K

Similar funds

Daiwa Securities Group's Q1 2019 Portfolio in Review

As of Q1 2019, Daiwa Securities Group held 1,217 positions worth $11.4B, up 9.8% from $10.4B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Daiwa Securities Group withdrew a net $761M in Q1 2019, closing 36 positions and reducing 355 holdings. Its most notable exit was CenterPoint Energy, Inc. Depositary Shares Each Representing a 1/20th Interest in a Share of 7.00% S, an estimated $15.1M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 74% of assets, down from 75% a quarter earlier, followed by Technology and Industrials.

Against the trend, Daiwa Securities Group opened a new position in Steris worth $13.7M.

  • Daiwa Securities Group's largest Q1 2019 buy was Steris: 106,969 shares worth $13.7M.
  • Daiwa Securities Group added most to Public Storage in Q1 2019, an estimated $250M increase.
  • Daiwa Securities Group's biggest Q1 2019 reduction was Vornado Realty Trust, cutting an estimated $172M.
  • Daiwa Securities Group fully exited CenterPoint Energy, Inc. Depositary Shares Each Representing a 1/20th Interest in a Share of 7.00% S in Q1 2019, selling an estimated $15.1M.
  • Daiwa Securities Group's ten largest holdings make up 39% of its $11.4B portfolio in Q1 2019.
  • Daiwa Securities Group opened 80 new positions and closed 36 in Q1 2019.
  • Daiwa Securities Group's portfolio value rose 9.8% quarter-over-quarter to $11.4B.

Based on Daiwa Securities Group's 13F filing for Q1 2019, filed 26 Apr 2019.